Australia markets closed

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.46+0.16 (+1.55%)
As of 11:32AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-49,527
-49,527
-42,815
-20,552
-3,668
Depreciation & amortisation
5,352
5,352
2,133
685
1,210
Stock-based compensation
17,352
17,352
8,111
3,409
919
Change in working capital
-9,743
-9,743
-5,809
-983
-4,174
Accounts receivable
-9,301
-9,301
-11,039
-4,226
-4,290
Inventory
-9,848
-9,848
-8,769
-2,741
-2,258
Accounts payable
3,167
3,167
4,612
1,791
1,334
Other working capital
-46,033
-46,033
-45,486
-19,898
-5,563
Other non-cash items
2,963
2,963
2,791
176
220
Net cash provided by operating activities
-34,575
-34,575
-30,648
-17,193
-4,494
Cash flows from investing activities
Investments in property, plant and equipment
-11,458
-11,458
-14,838
-2,705
-1,069
Acquisitions, net
-20,000
-20,000
0
-
-
Purchases of investments
-169,865
-169,865
-63,409
0
0
Sales/maturities of investments
120,024
120,024
1,729
0
0
Net cash used for investing activities
-81,299
-81,299
-76,518
-2,705
-1,069
Cash flows from financing activities
Debt repayment
0
0
-33,893
-1,788
-20,000
Common stock issued
107,527
107,527
0
107,610
0
Other financing activities
-
-
-989
-
-179
Net cash used provided by (used for) financing activities
109,383
109,383
20,806
107,652
11,503
Net change in cash
-6,491
-6,491
-86,360
87,754
5,940
Cash at beginning of period
19,473
19,473
105,833
18,079
12,139
Cash at end of period
12,982
12,982
19,473
105,833
18,079
Free cash flow
Operating cash flow
-34,575
-34,575
-30,648
-17,193
-4,494
Capital expenditure
-11,458
-11,458
-14,838
-2,705
-1,069
Free cash flow
-46,033
-46,033
-45,486
-19,898
-5,563